Yangjiang Hospital of Traditional Chinese Medicine Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00548223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Yangjiang City Hospital of TCM in Guangdong Province | Yangjiang Hospital of Traditional Chinese Medicine

Active Ingredients

Drugs in Phase 4 Trials (2)

deng zhan sheng mai (1 trial)

tongfusan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2